The estimated cost for pivotal (phase 3) studies for new
drugs approved by the FDA is over $41,000 per patient. As the cost per patient
continues to rise, it is critical to enhance patient engagement at every stage
of the clinical journey to improve the efficiency and effectiveness of patient
recruitment and retention.
Paresh Shah, CEO of MindLeaf
Patient Engagement Administrative Challenges
Are your patient engagement initiatives sub-optimized by inefficient data capture, data management, billing and compliance issues?
Are you looking to improve appointment management, symptom tracking and patient support to increase protocol compliance and reduce dropout rates?
Are you able to effectively address the social determinants of health when designing randomized control trials (RCTs) to test drug efficacy?
Are you looking to make trials more accessible through decentralization and patient apps?
Are looking for easier and more timely navigation through the administrative processes of clinical research?
To overcome these and other barriers to clinical trial success requires deep domain expertise in administrative, compliance and support services. Thats where MindLeaf can help.